IDS and NattoPharma invite you to attend our lunchtime symposium

Team meeting around a round table

Date & time: Sunday 22nd May 2016, 13:30 – 15:00

Lunch boxes will be served from 13:30

Location: Hall N, Austria Center Vienna, Vienna, Austria

The Infernal Triad:
Matrix Gla-Protein, Vitamin K and Vascular Calcification

Vascular mineralisation is currently recognised as an actively regulated process where it was previously regarded as a passive end-stage process. The discovery that the vitamin K-dependent matrix Gla-protein (MGP) is a strong inhibitor of vascular calcification (VC) has opened novel avenues for risk assessment and monitoring disease progression. The distinguished international faculty presentations, led by Prof. Jürgen Floege and Prof. Etienne Cavalier, will focus on the burden of VC in chronic kidney disease (CKD) by Prof. Ziad Massy; review pivotal data supporting the linkage of VC and MGP by Dr. Leon Schurgers; essential roles of vitamin K2 and the need for a reliable measurement to quantify vitamin K status by Dr. Katarzyna Maresz.

Programme

  • Chair’s welcome and introduction

Prof. Dr. Jürgen Floege MD, FERA

Director of the Department of Nephrology and Clinical Immunology

Vice Dean of Medical School

University of Aachen

Germany

  • Vascular calcification in CKD patients

Prof. Ziad A. Massy, MD, PhD, FERA

Chief, Division of Nephrology, Ambroise Paré Hospital

Co-Director, INSERM U-1018

Co-Director, CESP for UVSQ affairs

CESP Team 5 (EpReC, Renal & Cardiovascular Epidemiology) UVSQ

France

  • Vitamin K-dependent matrix Gla-Protein: a crucial switch to control ectopic mineralisation

Leon J. Schurgers, Ph.D.

Associate Professor of Biochemistry

Cardiovascular Research Institute Maastricht

University Maastricht

The Netherlands

  • Vitamin K2: an essential nutrient for cardiovascular health

Katarzyna Maresz, Ph.D.

President of the International Science and Health Foundation

Poland

  • Discussion

Prof. Dr. Jürgen Floege MD, FERA

Prof. Etienne Cavalier, PhD. EuSpLM

  • Closing remarks

Prof Etienne Cavalier, PhD. EuSpLM

Head, Department of Clinical Chemistry

University of Liège, CHU Sart-Tilman

Belgium